7,938 Janaushadhi centres functional across India: Mandaviya
"PMBJKs are functional in all the States/UTs, covering all districts of the country. As on 20.07.2021, 7,938 PMBJKs are functional across the country," Minister for Chemicals and Fertilizers Mansukh Mandaviya said in a written reply to the Lok Sabha. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 27, 2021 Category: Pharmaceuticals Source Type: news

SC notice to Centre on plea seeking directions for uniform healthcare standard
The plea has also sought directions for operationalising all the provisions of the Act, as well as Clinical Establishment Rules, 2012 in order to ensure affordable and quality healthcare. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 27, 2021 Category: Pharmaceuticals Source Type: news

Made in India Sputnik V to be available during September- October: Dr Reddy's
Dr Reddy's, which has tied up with Russian Direct Investment Fund for Sputnik V in India, soft launched the vaccine in India in May 2021 after receiving Emergency Use Authorization (EUA) in April 2021. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 27, 2021 Category: Pharmaceuticals Source Type: news

BDR Pharma inks license agreement with DRDO to produce COVID-19 drug 2-DG
Last month, the Drugs Controller General of India (DCGI) had approved the oral medication for emergency usage as adjuvant therapy in mild to severe COVID-19 patients. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 26, 2021 Category: Pharmaceuticals Source Type: news

Mixed AstraZeneca-Pfizer shot boosts COVID antibody level - study
A British study last month showed similar results - an AstraZeneca shot followed by Pfizer produced the best T-cell responses, and a higher antibody response than Pfizer followed by AstraZeneca. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 26, 2021 Category: Pharmaceuticals Source Type: news

India to miss end-July vaccination target as Bharat Biotech lags
India has undertaken one of the world's largest vaccination drives and has so far distributed some 430 million doses - more than any country except China, but less than many countries relative to its population. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 26, 2021 Category: Pharmaceuticals Source Type: news

Biocon Biologics gets licence from Adagio Therapeutics for antibody treatment of COVID-19
"ADG20, a novel monoclonal antibody targeting the spike protein of SARS-CoV-2 and related coronaviruses, is in global clinical development by Adagio as a single agent for both the treatment and prevention of COVID-19, the disease caused by the SARS-CoV-2 virus, its variants, as well as future variants that may emerge," it added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 26, 2021 Category: Pharmaceuticals Source Type: news

Brazil ’s health regulator scraps Bharat Biotech’s EUA application of Covaxin
The move comes after Anvisa was informed by Bharat Biotech that it ’s Brazilian partner-Necessidade no longer has authorization to represent them in Brazil. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 26, 2021 Category: Pharmaceuticals Source Type: news

Sun Pharma signs in-licensing deal to sell skincare drug in US
Acne, being the most prevalent skin condition in the US, affects up to 50 million Americans annually. The last FDA approval of an acne drug with a new mechanism of action (MOA) occurred nearly 40 years ago. Winlevi is expected to be available in the US in Q4 calendar 2021, added the statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 26, 2021 Category: Pharmaceuticals Source Type: news

Brazil suspends clinical trials of Bharat Biotech's Covaxin
“The Coordination of Clinical Research at Anvisa (Copec/GGMED) determined this Friday (23/7) the precautionary suspension of clinical studies of the Covaxin vaccine in Brazil,”Anvisa, the Brazilian health regulator said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 24, 2021 Category: Pharmaceuticals Source Type: news

Private hospital in Delhi records rise in neurological cases among post-Covid patient
In the out-patient department (OPD), up to 60 per cent of patients are presenting increasing mental health issues like anxiety, depression, suicidal thoughts, feeling of loneliness, and majority of these are post-Covid cases, the Moolchand Hospital said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 24, 2021 Category: Pharmaceuticals Source Type: news

Bharat Biotech commits to supply 500 million doses of Covaxin to Centre for immunisation programme
Speaking at a virtual conference organised by the Confederation of Indian Industry, Suchitra Ella, joint Managing Director of the city-based vaccine maker, said the companys facilities in four cities - Hyderabad, Bengaluru, Pune and Ankaleshwar - are currently producing Covaxin. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 23, 2021 Category: Pharmaceuticals Source Type: news

Bharat Biotech terminates MoU with Brazilian partners after graft allegations
Bharat Biotech had signed an MoU with Precisa Medicamentos and Envixia Pharmaceuticals LL.C on November 20 for the purpose of introducing Covaxin in the territory of Brazil. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 23, 2021 Category: Pharmaceuticals Source Type: news

Biocon eyes market share expansion in developed, emerging markets: Kiran Mazumdar-Shaw
“Trastuzumab (monoclonal antibody used to treat breast and stomach cancers) is another big opportunity we are looking at, not just in the US and Europe, but it is a very large global opportunity with growth potential for us,” Mazumdar-Shaw said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 23, 2021 Category: Pharmaceuticals Source Type: news

Only marginal difference in purchase price of Covishield, Covaxin for Centre: MoS Health
In fact, the Government of India has been supplying vaccines free of cost to the states/UTs for administration to prioritised beneficiaries as recommended by the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 23, 2021 Category: Pharmaceuticals Source Type: news

Global private equity funds in talks to purchase minority stake in BDR Pharmaceuticals
Funds like the Carlyle Group, Warburg Pincus and TA Associates are engaged in initial discussions, the people added. Investment bank O3 Capital is advising the promoters. In 2018, Shah had tried his luck to sell minority stake and had discussions with funds like Carlyle, but it did not fructify. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 23, 2021 Category: Pharmaceuticals Source Type: news

High court order on diabetes drug patent may reduce prices
The cost for treating diabetes is expected to come down with the Delhi high court having dismissed an appeal by AstraZeneca, which had sought the restraining of the generic versions of a blockbuster drug. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 22, 2021 Category: Pharmaceuticals Source Type: news

PAG to acquire contact manufacturer Acme Formulation
Founded in 2005 by Viral Shah, Acme provides contract development and manufacturing services to major Indian and global pharmaceutical companies. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 22, 2021 Category: Pharmaceuticals Source Type: news

Sudden surge in Covid cases in Russia delays Sputnik's commercial rollout in India
There has been a delay of 5-6 weeks due to the situation in Russia but the authorities hope that the process will smoothen by August-end or early September (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 21, 2021 Category: Pharmaceuticals Source Type: news

European Medicines Agency grants Orphan Drug Designation to Zydus Cadila's Saroglitazar Mg
Orphan Drug status in Europe is given to medicines with the potential to be safe and effective treatments for rare, life-threatening, or chronically debilitating conditions affecting no more than 5 people in 10,000 people. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 21, 2021 Category: Pharmaceuticals Source Type: news

Zydus Cadila gets tentative nod from USFDA to market cancer drug
"Ibrutinib belongs to a class of drugs known as kinase inhibitors and is used to treat certain cancers, such as mantle cell lymphoma or marginal zone lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma, and Waldenstrom's macroglobulinemia," Zydus Cadila said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 21, 2021 Category: Pharmaceuticals Source Type: news

Serum Institute writes to Union Health Minister proposing reforms in drug regulatory system
The letter stated that on the directions of the prime minister, a high-powered Inter-Ministerial Committee for reforming the drug regulatory systems in India was formed. "Recommendations of this inter-ministerial committee should be implemented immediately in line with 'ease of doing business". (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 21, 2021 Category: Pharmaceuticals Source Type: news

WHO assessing Covaxin data for emergency use listing; decision date 'to be confirmed'
Suchitra Ella, joint managing director of Bharat Biotech, had recently said the EUL process is a step closer to the final decision on Covaxin's 'global acceptance' as the rolling data was slated to begin in July. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 20, 2021 Category: Pharmaceuticals Source Type: news

4 Covid vaccine candidates in human trial stage, 1 in pre-clinical stage, govt tells Rajya Sabha
In a written response to a question in the Rajya Sabha, Union Science and Technology Minister Jitendra Singh said Cadila Healthcare Ltd's DNA-based vaccine candidate is in phase three clinical trial. It has also submitted the interim data for emergency use authorisation. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 20, 2021 Category: Pharmaceuticals Source Type: news

Process to receive WHO pre-qualification for Covaxin on: Govt
In response to a question on when the WHO approval for Covaxin is expected, the minister said the data required for approval was submitted by Bharat Biotech International to WHO on July 9. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 20, 2021 Category: Pharmaceuticals Source Type: news

Costs of raw material for drugs rise by up to 140%
API prices of certain drugs like fever and pain relief drug paracetamol and life-saving antibiotic Meropenem (also used for Covid), and anti-diabetic metformin, have more than doubled to as high as 139%, 127% and 124% respectively, putting the spotlight back on India ’s near total-dependence on the Dragon. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 20, 2021 Category: Pharmaceuticals Source Type: news

WHO assessing Covaxin data for EUL; decision date 'to be confirmed'
Suchitra Ella, joint managing director of Bharat Biotech, had recently said the EUL process is a step closer to the final decision on Covaxin's 'global acceptance' as the rolling data was slated to begin in July. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 20, 2021 Category: Pharmaceuticals Source Type: news

Bharat Biotech ’s dossier under review for Covaxin Emergency Use Listing: WHO
(Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 19, 2021 Category: Pharmaceuticals Source Type: news

Alkem looks for partnerships, in-licensing deals to bolster presence in US market
"The company would also strategically look at in-licensing opportunities, alliances and partnerships to enhance its capabilities and product portfolio, gaining further legroom for growth in the US market," Alkem Laboratories said in its Annual Report for 2020-21. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 18, 2021 Category: Pharmaceuticals Source Type: news

India needs to diversify pharma raw material imports, up R & D spends: RBI paper
"The high import dependency and surprisingly low R&D intensity of exports in the Indian pharmaceutical sector call for timely diversification of source countries for importing raw materials so as to mitigate potential supply-side bottlenecks," the paper by Shibanjan Dutta and Dhirendra Gajbhiye said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 15, 2021 Category: Pharmaceuticals Source Type: news

Pfizer, Johnson and Johnson yet to apply for COVID-19 vaccines licence in India: Sources
Another giant pharma company Moderna is supposed to donate seven million doses to India from the United States under Covax is still pending. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 15, 2021 Category: Pharmaceuticals Source Type: news

USFDA issues import alert on Jubilant Pharmova's Roorkee plant
The US Food and Drug Administration (USFDA) has taken the action after conducting an inspection of the formulations plant in March this year, the drug maker said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 15, 2021 Category: Pharmaceuticals Source Type: news

Venus Remedies launches consumer healthcare division
The R3SET Life formula ensures maximum efficacy by combining the goodness of proven essential oils with nanotechnology to provide instant relief and long-term healing, it added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 15, 2021 Category: Pharmaceuticals Source Type: news

Zydus Cadila seeks approval for its needle-free COVID vaccine ZyCOV-D; here's how it works
According to a TOI report, Ahmedabad-based Zydus Cadila, which is also one of the companies developing coronavirus vaccine, has sought emergency use approval for its three dose, needle-free COVID-19 vaccine, ZyCOV-D (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 14, 2021 Category: Pharmaceuticals Source Type: news

Scrap taxes on drug import for spinal muscular atrophy, Stalin tells Centre
For children affected by SPA, gene-therapy has to be ideally given before the child reaches two years of age and this therapy costs over Rs 16 crore per person, Stalin said in a letter to union finance minister Nirmala Sitharaman. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 13, 2021 Category: Pharmaceuticals Source Type: news

Remdesivir, hydroxychloroquine show no antiviral effect against COVID-19: Study
The study, published in the journal Annals of Internal Medicine, evaluated the effects of the two drugs on all-cause, in-hospital mortality, the degree of respiratory failure and inflammation, and viral clearance in the oropharynx. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 13, 2021 Category: Pharmaceuticals Source Type: news

Sputnik V soft launched in over 50 cities in India: Dr Reddy's
"Starting initially in Hyderabad today, the soft launch rollout of Sputnik V has scaled up speedily and reached cities and towns all over India- including but not limited to Hyderabad, Vizag, Bengaluru, Mumbai, Navi Mumbai, Kolkata, Delhi, NCR, Chennai, Miryalaguda, Vijayawada, Baddi, Kolhapur, Kochi, Raipur, Chandigarh, Pune, Nagpur, Nashik," Dr Reddy's said in a tweet. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 13, 2021 Category: Pharmaceuticals Source Type: news

Vaccinated and confused? Answers about masks, the Delta variant and breakthrough infections
Mask mandates are largely intended to protect the unvaccinated. Since you can ’t always tell who is vaccinated and who is not, telling everyone to wear a mask can help stop the spread of the virus by people who are infected but don’t have any symptoms. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 13, 2021 Category: Pharmaceuticals Source Type: news

All documents for Covaxin emergency use listing submitted to WHO, expect approval at earliest: Bharat Biotech
According to WHO guidelines, EUL is a procedure to streamline the process by which new or unlicensed products can be used during public health emergencies. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 12, 2021 Category: Pharmaceuticals Source Type: news

Documents for Covaxin emergency use listing submitted to WHO, expect approval at earliest: Bharat Biotech
According to WHO guidelines, EUL is a procedure to streamline the process by which new or unlicensed products can be used during public health emergencies. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 12, 2021 Category: Pharmaceuticals Source Type: news

Documents for Covaxin emergency use listing submitted to WHO; expect approval at earliest: Bharat Biotech
According to WHO guidelines, EUL is a procedure to streamline the process by which new or unlicensed products can be used during public health emergencies. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 12, 2021 Category: Pharmaceuticals Source Type: news

FDC launches Favipiravir oral suspension to treat COVID-19 in India
In order to combat COVID-19, we believe in offering best efficacy along with convenience to our patients and as such we have focused our efforts in making the process of COVID-19 treatment hassle-free," FDC Business Development& Commercial Excellence General Manager Mayank Tikkha said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 12, 2021 Category: Pharmaceuticals Source Type: news

New Covid diagnostic test could detect coronavirus infection in seconds
Mumbai-based company MediCircle Health Pvt Ltd has used Israeli technology to detect Covid-19 in saliva swab or gargled water within seconds. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 12, 2021 Category: Pharmaceuticals Source Type: news

Sputnik V second dose shortage to delay India's full rollout: Dr Reddy's
Dr. Reddy's had received about 3 million first doses by June 1 and about 360,000 doses of the second by early this month, the company and the Indian government have said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 12, 2021 Category: Pharmaceuticals Source Type: news

Pluss Advanced Tech to supply boxes for transport of Sputnik V vaccine in India
As per the company, the box can maintain inside-temperature passively, without electricity, at desired levels for more than 100 hours and serve as an energy efficient and safer alternative to refrigerated containers, conventional ice-packs or even dry ice, which are considered hazardous, unsustainable and unsafe for carrying in airlines. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 12, 2021 Category: Pharmaceuticals Source Type: news

India's most purchased drugs in the last decade are for cardiac ailments, diabetes
At around Rs 21,000 crore annually, cardiac medication forms the biggest therapy of drugs being bought by Indians today. A decade ago, it was a third of its size and the second largest-therapy by sales. At around Rs 16,000 crore, anti-diabetes medication today is the fourth-largest therapy of drugs sold in the country. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 10, 2021 Category: Pharmaceuticals Source Type: news

Decision on emergency use listing of Covaxin likely in 4-6 weeks: WHO
According to WHO guidelines, EUL is a procedure to streamline the process by which new or unlicensed products can be used during public health emergencies. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 10, 2021 Category: Pharmaceuticals Source Type: news

Venus Remedies announces Covid protection policy
Under the policy, the company will pay an amount equivalent to one month of gross salary for the next 12 months to the nominated dependents of permanent employees in case of their untimely demise due to Covid-19, according to a company statement here. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 10, 2021 Category: Pharmaceuticals Source Type: news

India's most purchased drugs in the last decade are for cardiac ailments and diabetes
At around Rs 21,000 crore annually, cardiac medication forms the biggest therapy of drugs being bought by Indians today. A decade ago, it was a third of its size and the second largest-therapy by sales. At around Rs 16,000 crore, anti-diabetes medication today is the fourth-largest therapy of drugs sold in the country. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 10, 2021 Category: Pharmaceuticals Source Type: news

Genetic flashpoints: Why Covid-19 hits some people harder than others
The Nature report summarizes information from 46 studies and three meta-analyses investigating the role of human genetics in Sars-CoV-2 infections and Covid-19 severity. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 10, 2021 Category: Pharmaceuticals Source Type: news